A 3-Week, Open Label Study to Evaluate the Efficacy and Safety of Extended Release Quetiapine Fumarate in the Treatment of Agitation in Patients with Schizophrenia
Objective: To evaluate the efficacy of extended-release quetiapine fumarate (XR) monotherapy once daily, in the treatment of patients with acute episodes of schizophrenia and agitation. Method: Our study was a 3-week open-label study conducted in adult in- or outpatients with schizophrenia. Quetia...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | en |
| Published: |
Taylor & Francis
2013
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/9622/1/00000797_93562.pdf http://eprints.um.edu.my/9622/ https://doi.org/10.5455/bcp.20130127022922 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|